| Announce Date | 09/16/2025 |
| EPS Normalized Actual | $-0.07009 (Beat by $0.02991) |
| EPS GAAP Actual | $-0.07009 (Beat by $0.02991) |
| Revenue Actual | $0.016737B |
| Revenue Surprise | Beat by $16.737M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $-0.01 |
| EPS GAAP Estimate | $-0.01 |
| Revenue Estimate | $0.017678B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2030 | 1.23 | 1.92 | 1.1723 | 1.2877 | 1 |
| Jun 2029 | 0.84 | 2.81 | 0.82587 | 0.86119 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.07 | -0.07 | 0.016737B | 20.98% | 16.74M |
| FQ1 2025 (Mar 2025) | -0.12 | -0.155 | 0.016742B | 13.65% | -2.86M |
| FQ3 2024 (Sep 2024) | -0.1 | -0.1 | 0.016125B | 8.24% | 16.13M |
| FQ4 2024 (Dec 2024) | -0.11 | -0.035 | 0.01683B | -9% | 2.33M |
| FQ2 2024 (Jun 2024) | 0.34 | 0.34 | 0.013226B | -22.88% | 13.23M |
| FQ1 2024 (Mar 2024) | -0.16 | -0.16 | 0.014457B | -4.36% | 14.46M |
| FQ4 2023 (Dec 2023) | -0.0493 | -0.0493 | 0.018344B | 6.47% | 18.34M |
| FQ3 2023 (Sep 2023) | -0.13 | -0.13 | 0.014797B | 100% | 14.8M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.01
Consensus Revenue Estimates
0.017678B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 0.04 | -- | 0.03852376 | 0.04095521 | 1 |
| FQ4 2026 (Dec 2026) | 0.06 | -- | 0.05533758 | 0.06464666 | 1 |
| FQ3 2026 (Jul 2026) | 0.06 | -- | 0.05841275 | 0.06206483 | 0 |
| FQ1 2026 (Mar 2026) | 0.12 | 200 | 0.11442 | 0.12705 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ4 2026 (Dec 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
| FQ3 2026 (Jul 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
| FQ1 2026 (Mar 2026) | 0.03B | 37.76 | 0.03B | 0.03B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.07 | -0.07 | 100% | |
| FQ1 2025 (Mar 2025) | 0.035 | -0.12 | -0.155 | 129.17% |
| FQ3 2024 (Sep 2024) | -0.1 | -0.1 | 100% | |
| FQ4 2024 (Dec 2024) | -0.075 | -0.11 | -0.035 | 31.82% |
| FQ2 2024 (Jun 2024) | 0.34 | 0.34 | 100% | |
| FQ1 2024 (Mar 2024) | -0.16 | -0.16 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0493 | -0.0493 | 100% | |
| FQ3 2023 (Sep 2023) | -0.13 | -0.13 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0.02B | $16.74M | 100% |
| FQ1 2025 (Mar 2025) | $0.02B | $0.02B | $-2.86M | -17.07% |
| FQ3 2024 (Sep 2024) | $0B | $0.02B | $16.13M | 100% |
| FQ4 2024 (Dec 2024) | $0.01B | $0.02B | $2.33M | 13.84% |
| FQ2 2024 (Jun 2024) | $0B | $0.01B | $13.23M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.01B | $14.46M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.02B | $18.34M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $0.01B | $14.8M | 100% |